There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and several have been approved for emergency or full use on six continents. In the US, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- NASA at Princeton: Hands-on lab trains students in teamwork, building space equipment.
- Discovering a New Way to Measure Poverty.
- Rutgers’ Protein Data Bank Powers a New Era in Structural Biology.
- How Nature Can Make Urban Dwellers Healthier.
- How Better Software Choices Could Cut U.S. Health Care Costs.
Categories
- Community (2,377)
- Covid (992)
- CTO Events (6)
- News (3,014)
- Pilots (21)